Recent findings suggest that METTL1 can upregulate the WNT/β-catenin signaling pathway, promoting NPC cell chemoresistance to cisplatin and docetaxel and epithelial-mesenchymal transition (EMT) in vitro and in vivo [27]. This evidence concerns the gene METTL1 and nasopharyngeal carcinoma.